Serina Therapeutics Director Purchases Shares Amid Executive Shift and Analyst Coverage
Serina Therapeutics, Inc. (NASDAQ: SER) reported a recent equity transaction involving board member Stephen K. Brannan, who purchased 1,000 shares of the company's common stock on July 7, 2026. The acquisition, valued at $2,029, brings Brannan's direct holdings to 1,000 shares. This transaction occurs alongside broader corporate developments, inclu…